Can toxicities induced by antituberculosis drugs be better managed in diabetic patients?

Eur Respir J. 2017 Jul 20;50(1):1700409. doi: 10.1183/13993003.00409-2017. Print 2017 Jul.

¹ Stanley Ho Centre for Emerging Infectious Diseases, Faculty of Medicine, The Chinese University of Hong Kong, Hong Kong, China.
² Stanley Ho Centre for Emerging Infectious Diseases, Faculty of Medicine, The Chinese University of Hong Kong, Hong Kong, China denisechan@cuhk.edu.hk.
³ Tuberculosis and Chest Service, Centre for Health Protection, Department of Health, Hong Kong, China.
⁴ Department of Molecular Microbiology and Immunology, Bloomberg School of Public Health, Johns Hopkins University, Baltimore, MD, USA.
⁵ State Key Laboratory of Quality Research in Chinese Medicine and Institute of Chinese Medical Sciences, University of Macau, Macao, China.

No abstract available

Publication types